RecruitingNCT06430528
A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
Studying Endogenous Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Michigan
- Principal Investigator
- Richard Auchus, MD, PhD, MDUniversity of Michigan
- Intervention
- Osilodrostat(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- University of Michigan, Ann Arbor, Michigan, United States
Collaborators
RECORDATI GROUP
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06430528 on ClinicalTrials.gov